MPR: Concise prescription and OTC drug information, side effects and interactions for medical professionals

Achieving Treatment Success for Patients with Heart Failure Complicated by Hyponatremia

1.50 AMA PRA Category 1 Credit(s)^TM
1.50 CE for Nurses
1.50 CE for Pharmacists

Thyroid Functional Disease in Dialysis Patients

1.00 AMA PRA Category 1 Credit(s)^TM

Pretreatment Percutaneous Biopsy of Small Renal Masses

1.00 AMA PRA Category 1 Credit(s)^TM

New paradigms in managing chronic kidney disease

0.50 AAPA Category I CME Credit
0.50 CE for Nurses

Management of diabetes in patients with endstage kidney disease Prescreening of adolescent athletes How much evaluation is enough

1.00 AAPA Category I CME Credit

The Evaluation and Treatment of Resistant Hypertension

1.00 AMA PRA Category 1 Credit(s)^TM

New Drug Review from MPR September 2012

1.00 AMA PRA Category 1 Credit(s)^TM
1.00 CE for Pharmacists

An Update on the Management of Lupus Nephritis

1.00 AMA PRA Category 1 Credit(s)^TM

Clinical Challenges and Renal Considerations in Managing Gout Part III

1.00 AMA PRA Category 1 Credit(s)^TM

Managing Bone Disease in Kidney Transplant Recipients

1.00 AMA PRA Category 1 Credit(s)^TM

Clinical Challenges and Renal Considerations in Managing Gout Part II

1.00 AMA PRA Category 1 Credit(s)^TM

Clinical Challenges and Renal Considerations in Managing Gout Part I

1.00 AMA PRA Category 1 Credit(s)^TM

The Management of Patients After Renal Transplantation

1.00 AMA PRA Category 1 Credit(s)^TM

An Update on RoboticAssisted Partial Nephrectomy

1.00 AMA PRA Category 1 Credit(s)^TM

A Nephrologic Perspective on the Management of Gout

1.00 AMA PRA Category 1 Credit(s)^TM

Chronic Kidney Disease and Cardiovascular Risk A Perfect Storm Nurse Practitioners Pharmacology Credit available

1.00 AAPA Category I CME Credit
1.00 CE for Nurses

Hyponatremia An Update on the Management of SIADH

1.00 AMA PRA Category 1 Credit(s)^TM

CauseSpecific Outcomes Associated with Hypovitaminosis D Part 2

1.00 AMA PRA Category 1 Credit(s)^TM

Vitamin D and Clinical Outcomes in Patients With and Without CKD Part 1

1.00 AMA PRA Category 1 Credit(s)^TM

IgA Nephropathy An Update on Diagnosis and Management

1.00 AMA PRA Category 1 Credit(s)^TM

Classifying Histologic Subtypes of Renal Cell Carcinoma

1.00 AMA PRA Category 1 Credit(s)^TM

Parathyroid Hormone, Alkaline Phosphatase and FGF23

1.00 AMA PRA Category 1 Credit(s)^TM

Browse drugs by:

Achieving Treatment Success for Patients with Heart Failure Complicated by Hyponatremia

Thyroid Functional Disease in Dialysis Patients

Pretreatment Percutaneous Biopsy of Small Renal Masses

New paradigms in managing chronic kidney disease

Management of diabetes in patients with endstage kidney disease Prescreening of adolescent athletes How much evaluation is enough

The Evaluation and Treatment of Resistant Hypertension

New Drug Review from MPR September 2012

An Update on the Management of Lupus Nephritis

Clinical Challenges and Renal Considerations in Managing Gout Part III

Managing Bone Disease in Kidney Transplant Recipients

Clinical Challenges and Renal Considerations in Managing Gout Part II

Clinical Challenges and Renal Considerations in Managing Gout Part I

The Management of Patients After Renal Transplantation

An Update on RoboticAssisted Partial Nephrectomy

A Nephrologic Perspective on the Management of Gout

Chronic Kidney Disease and Cardiovascular Risk A Perfect Storm Nurse Practitioners Pharmacology Credit available

Hyponatremia An Update on the Management of SIADH

CauseSpecific Outcomes Associated with Hypovitaminosis D Part 2

Vitamin D and Clinical Outcomes in Patients With and Without CKD Part 1

IgA Nephropathy An Update on Diagnosis and Management

Classifying Histologic Subtypes of Renal Cell Carcinoma

Parathyroid Hormone, Alkaline Phosphatase and FGF23

MPR Articles